NEW YORK (GenomeWeb News) — Hologic reported after the close of the market on Wednesday a 2 percent increase in fiscal second quarter revenues despite a 2 percent decrease in sales for its Diagnostics segment.

For the three months ended March 29, the Bedford, Mass.-based company reported revenues of $625 million compared to $612.7 million in the same quarter last year but besting the average Wall Street estimate of $609 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.